Description: Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It prefers to invest in life sciences, medical devices, biopharmaceutical technologies, and biotechnology companies. The firm seeks to invest in companies based in United States, and Israel. It invests between $0.5 million and $10 million per company. It takes a seat on the board of directors of the companies it invests in. It invests through personal capital of its management. The firm acts as a lead investor and major shareholder in its portfolio companies. Clal Biotechnology Industries Ltd. was founded in July, 1998 and is based in Tel Aviv, Israel with an additional office in Cambridge, Massachusetts. It operates as a former subsidiary of Clal Industries and Investments Ltd.
Home Page: www.cbi.co.il
Azrieli Center
Tel Aviv,
67023
Israel
Phone:
972 3 612 1616
Officers
| Name | Title |
|---|---|
| Mr. Assaf Segal | Acting Chief Exec. Officer |
| Ms. Etty Kliger | VP of R&D - MediWound |
| Prof. Lior Rosenberg M.D. | VP of Medical Technologies - MediWound |
| Ms. Iris Sadeh | Accountant |
| Ms. Liat Nissan | Controller |
| Ms. Shiran Manor | Corp. Sec. |
| Dr. Arnon Aharon M.D. | Medical Director |
Exchange: TA
Country: IL : Israel
Currency: Israeli Agora (ILA)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.6776 |
| Price-to-Sales TTM: | 2.7874 |
| IPO Date: | 2007-06-03 |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |